164 related articles for article (PubMed ID: 16735417)
1. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.
Coenen S; Ferech M; Malhotra-Kumar S; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):418-22. PubMed ID: 16735417
[TBL] [Abstract][Full Text] [Related]
2. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.
Coenen S; Ferech M; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):413-7. PubMed ID: 16735416
[TBL] [Abstract][Full Text] [Related]
3. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):401-7. PubMed ID: 16735414
[TBL] [Abstract][Full Text] [Related]
4. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):423-7. PubMed ID: 16735418
[TBL] [Abstract][Full Text] [Related]
5. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe.
Ferech M; Coenen S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):408-12. PubMed ID: 16735415
[TBL] [Abstract][Full Text] [Related]
6. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.
Coenen S; Muller A; Adriaenssens N; Vankerckhoven V; Hendrickx E; Goossens H;
J Antimicrob Chemother; 2009 Jul; 64(1):200-5. PubMed ID: 19383728
[TBL] [Abstract][Full Text] [Related]
7. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002).
Vander Stichele RH; Elseviers MM; Ferech M; Blot S; Goossens H;
J Antimicrob Chemother; 2006 Jul; 58(1):159-67. PubMed ID: 16698845
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations.
Elseviers MM; Ferech M; Vander Stichele RH; Goossens H;
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):115-23. PubMed ID: 16700079
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.
Goossens H; Ferech M; Coenen S; Stephens P;
Clin Infect Dis; 2007 Apr; 44(8):1091-5. PubMed ID: 17366456
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic consumption and link to resistance.
Goossens H
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():12-5. PubMed ID: 19366364
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
Payerl-Pal M
Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
[TBL] [Abstract][Full Text] [Related]
12. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
[TBL] [Abstract][Full Text] [Related]
13. [Occurrence of macrolide-lincosamide-streptogramin B resistant isolates of Staphylococcus aureus in clinical specimens in 2003-2004].
Kaczmarek A; Budzyńska A; Gospodarek E
Med Dosw Mikrobiol; 2006; 58(2):103-11. PubMed ID: 17133903
[TBL] [Abstract][Full Text] [Related]
14. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
[TBL] [Abstract][Full Text] [Related]
15. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
17. Regional variation in outpatient antibiotic prescribing in Germany.
Kern WV; de With K; Nink K; Steib-Bauert M; Schröder H
Infection; 2006 Oct; 34(5):269-73. PubMed ID: 17033751
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and mechanisms of macrolide resistance among Staphylococcus epidermidis isolates from neutropenic patients in Tunisia.
Bouchami O; Achour W; Ben Hassen A
Clin Microbiol Infect; 2007 Jan; 13(1):103-6. PubMed ID: 17184298
[TBL] [Abstract][Full Text] [Related]
19. [Inducible resistance to macrolide-lincosamide-streptogramin type B antibiotics in Bacillus licheniformis: common structures of macrolide antibiotics capable of inducing the resistance].
Kobayashi H; Endou K; Nakajima Y
Yakugaku Zasshi; 1993 Mar; 113(3):264-71. PubMed ID: 8509994
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic use among children in British Columbia, Canada.
Marra F; Patrick DM; Chong M; Bowie WR
J Antimicrob Chemother; 2006 Oct; 58(4):830-9. PubMed ID: 16921182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
